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Abstract
It has been suggested that Echinacea has anti-inflammatory activity in vivo. Nitric oxide (NO), tumor
necrosis factor-alpha (TNF-α), and interleukin-1beta are important mediators in the inflammatory
response. The effect of alcohol extracts of E. angustifolia (EA), E. pallida (EPA) and E. purpurea
(EP) on the production of these inflammatory mediators in both LPS-stimulated RAW 264.7
macrophages in vitro and murine peritoneal exudate cells (PECs) in vivo were investigated. As
macrophages produce these inflammatory mediators in response to pathogenic infection, parallel
cultures of macrophages were studied for phagocytosis and intracellular killing of Salmonella
enterica. EPA and EP in vitro inhibited NO production and TNF-α release in a dose-dependent
manner. RAW 264.7 cells treated with EA or EP showed decreased killing over 24 h, although EA
enhanced bacterial phagocytosis. Upon bacterial infection, RAW 264.7 cells produce high levels of
NO; however, an Echinacea-mediated decrease in NO production was observed. Echinacea alcohol
extracts administered orally at 130 mg/kg per day for seven days had a weak effect on NO production
and phagocytosis by LPS-stimulated PECs. The results indicated that all Echinacea species
significantly decreased inflammatory mediators in vitro, however, only EA and EP reduced bacterial
killing. Oral administration of Echinacea alcohol extracts did not adversely affect the development
and anti-bacterial function of inflammatory PECs in vivo, however, NO production was decreased
during bacterial infection of PECs.
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Introduction
The genus Echinacea is a popular natural immunostimulant. Reports indicate that Echinacea
increases phagocytosis by neutrophils and macrophages, and stimulates these inflammatory
cells to produce proinflammatory cytokines and free radicals (Stimpel et al. 1984; Steinmuller
et al. 1993; Burger et al. 1997; Goel et al. 2002), which are responsible for the antimicrobial
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activity. Contrary to these reports, Echinacea is also used as an anti-inflammatory agent. The
anti-inflammatory effects have been demonstrated using murine inflammatory models, such
as carrageenan-induced paw edema and abraded skin (Tubaro et al. 1987; Raso et al. 2002;
Speroni et al. 2002). These seemingly contradictory, but interdependent biological activities
of Echinacea products are, to a very large extent, related to their immunomodulating properties
and may be due to the variability in composition of the herb products utilized in each study
(Percival 2000). Several active components have been identified in Echinacea, including
lipophilic alkamides, polar caffeic acid derivatives (mainly echinacoside and cichoric acid)
and high molecular weight polysaccharides (Barnes et al. 2005). In the current herbal market,
Echinacea products are a mixture of many varieties and may be blended with other herbs in
various forms, making it difficult to clarify which components play a predominant role in the
immunomodulatory activity. The interaction between the components of Echinacea crude
preparations is also unclear. The effects of Echinacea products might also depend on the host
condition. Echinacea may enhance immune function in the body with a weakened immune
system (Currier & Miller 2000; Bodinet et al. 2002), but suppress it when an inflammatory
response predominates. Our previous animal study found that Echinacea treatment restored
mild stress-induced immune changes to normal levels (Zhai et al. 2007).
The inflammatory response in vivo involves infiltration of macrophages that function through
secretion of inflammatory mediators, i.e. tumor necrosis factor-alpha (TNF-α),
interleukin-1beta (IL-1β) and nitric oxide (NO) (Park & Barbul 2004). The inflammatory
cytokines TNF-α and IL-1β enhance phagocytosis by macrophages and trigger the release of
NO (Nussler & Billiar 1993). NO, a signal of macrophage activation, is central to macrophage
cytostatic and cytotoxic activity against various bacteria and tumor cells (MacMicking et al.
1997; Burgner et al. 1999). However, when produced in excessive quantities, NO is detrimental
to both pathogenic agents and the host’s own tissues (Brune et al. 1997; Chang et al. 2000).
Therefore, production of NO and other inflammatory mediators is tightly regulated by a set of
complex anti-inflammatory mechanisms which involve IL-4 and IL-10 (Sato et al. 1999;
Salmon-Her et al. 2000). Our previous ex vivo observations show that orally administered
alcohol extracts of Echinacea increased the production of IL-4 and IL-10, but inhibited TNF-
α and IL-1β secretion by mitogen-stimulated splenocytes (Zhai et al. 2007). Other research
groups show that the alkamides from Echinacea downregulate NO production in activated
macrophages in vitro (Chen et al. 2005) and decrease TNF-α release in LPS-stimulated human
whole blood cells ex vivo (Woelkart et al. 2006). These studies suggest that alcohol extracts of
Echinacea as well as its alkamide fraction possess anti-inflammatory activity.
In this study, the effects of alcohol extracts of the three commonly used Echinacea species –
E. angustifolia (EA), E. pallida (EPA), and E. purpurea (EP) – were further examined both
in vivo and in vitro by determining the production of inflammatory mediators, NO, TNF-α and
IL-1β in activated macrophages. Parallel cultures of ex vivo macrophages and the macrophage
cell line RAW 264.7 cells were studied for phagocytosis and intracellular killing of
Salmonella in order to understand if Echinacea alcohol extracts compromise the antibacterial
function of macrophages through inhibition of inflammatory mediators.
Materials and methods
Preparation of alcohol extracts
The plants EA, EPA and EP were harvested in the USDA North Central Regional Plant
Introduction Station (Ames, IA, USA) with the identification numbers PI 631285, PI 631293
and PI 631307, respectively. Alcohol extracts from the dried roots were prepared as previously
described (Zhai et al. 2007) followed by evaporation until dry. These dry residues were
subsequently dissolved in ethanol and phosphate buffed saline (PBS) to desired concentrations
for in vitro assays or dissolved in ethanol and Nanopure water for animal studies. The extracts
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used for in vitro assays were further filter-sterilized using a 0.45-μm microfilter (Costar,
Corning, NY, USA). Aliquots of alcohol extracts were stored at −80°C (for in vitro assays) or
−20°C (for animal studies) and freshly thawed for each experiment. The endotoxin levels were
evaluated in aliquots using the Limulus Amebocyte Lysate Test (BioWhittaker, Inc.,
Walkersville, MD, USA) according to the manufacturer’s specifications for a microplate assay,
and were detected to be below the limit of detection (0.1 EU/ml). Phytochemical analysis was
performed to detect alkamides and caffeic acid derivatives in aliquots using high performance
liquid chromatography (HPLC) as described previously (Wu et al. 2004).
Animals
Animal care and experimental procedures were approved by the Iowa State University
Committee on Animal Care. Male BALB/c mice, 8 weeks of age, were obtained through Iowa
State University Laboratory Animal Resources from Harlan Laboratories (Indianapolis, IN,
USA) and allowed to acclimatize to the new environment for 2 weeks. The mice were housed
three per cage and provided free access to food and water under a reverse 12 h light/dark
regimen (lights off at 09:00 h).
Echinacea administration in vivo
The mice were randomly assigned to five groups. Groups 1–3 were gavaged with one of the
three alcohol extracts. Group 4 was gavaged with an equal volume of 5% ethanol as vehicle
control. Group 5 served as a no gavage control. The vehicle control and the no gavage control
were established to control for the effects of the vehicle in addition to handling stress. The
extracts were orally administered to the animals at 130 mg/kg body weight once daily for seven
consecutive days. This dosage and regimen was chosen based on an extrapolation of the
maximum dose recommended for humans and calculated as previously described (Zhai et al.
2007). Three days prior to euthanasia, all mice were injected intraperitoneally with 3% proteose
peptone (Difco Laboratories, Detroit, MI, USA) to induce an inflammatory cell response. The
animal experiment was repeated three times.
Peritoneal exudate cell collection
Some 12–15 h after the last gavage, the mice were euthanized by CO2 asphyxiation, and PECs
were immediately collected by peritoneal lavage with ice-cold EDTA (0.1%; w/v) in Hank’s
balanced salt solution (Fortier & Falk 1994). For each group, PECs were pooled and washed
twice with RPMI 1640 medium supplemented with 2 mM glutamine, 25 mM Hepes, 50 μg/ml
gentamicin and 10% heated-inactivated fetal bovine serum (complete medium).
Macrophage cell line
The murine peritoneal macrophage cell line RAW 264.7 cells were acquired from American
Type Culture Collection (ATCC; Rockville, MD, USA) and passaged in complete medium
with heated-inactivated iron-fortified bovine calf serum (JRH Biosciences, Lenexa, KS, USA)
at 37°C in a 7% CO2 incubator. Cells between passage 5 and 20 were used in this study.
Cell viability assay
Mitochondrial reduction of MTS, a tetrazolium compound, to a colored formazan was
determined as an indicator of cell viability. RAW 264.7 cells and PECs were seeded at 4 ×
104 cells per well in 96-well tissue culture plates with or without 1 μg/ml lipopolysaccharide
(LPS; E. coli 055:B5, L6529; Sigma, St. Louis, MO, USA). For cultures of RAW 264.7 cells,
one of the alcohol extracts was added at 0–500 μg/ml at the same time the cells were plated in
the absence or presence of LPS. After overnight incubation, MTS (Promega, Madison, WI,
USA) was added and cultures then successively incubated for 3 (PECs) or 1 (RAW 264.7 cells)
h. The extent of formazan formation was determined photometrically at absorbance 490 nm
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using a Bio Kinetics Reader (Bio-Tek Instruments, Winooski, VT, USA). The absorbance of
cell-free complete medium with or without vehicle or Echinacea alcohol extracts was used as
a blank and subtracted from the value of the corresponding treatment groups.
Growth and freezing of Salmonella
Salmonella enterica subspecies enterica serovar Typhimurium were obtained from Dr H. Harris
(Iowa State University) and grown overnight at 37°C in Luria-Bertani (LB) broth with shaking
to a density of 109 cells/ml. The Salmonella were washed once in PBS and frozen at −80°C in
LB broth containing 16% sterile glycerol. A freshly thawed aliquot of Salmonella was used
for each experiment.
Gentamicin protection assays
The engulfment and killing of Salmonella were performed using both RAW 264.7 cells and
PECs. The protocol for each cell type was identical with the exception that Echinacea alcohol
extracts were added to cultures of RAW 264.7 cells. PECs were collected from mice that had
been gavaged with one of the alcohol extracts in vivo. RAW 264.7 cells and PECs were seeded
at a concentration of 4 × 105 cells per well (1 ml) in 24-well plates and incubated overnight.
After harvesting the culture supernates for NO and cytokine assays, described below, cells
were washed three times in gentamicin-free complete medium. Salmonella were then added
to the adherent RAW 264.7 cells and PECs at a multiplicity of infection (MOI) of 100 bacteria
per cell. Following 2 h of infection, cells were washed in warm complete medium containing
50 μg/ml of gentamicin and maintained in gentamicin-containing complete medium for the
remainder of the experiment to kill all extracellular bacteria. At 0, 4 and 24 h post-infection,
one set of parallel cell cultures were washed with sterile PBS to remove gentamicin and then
lysed in distilled water to release the intracellular bacteria. Intracellular bacteria were
enumerated by serial dilution and plate count on LB agar. Lysate dilutions on LB agar were
incubated overnight at 37°C and counts were expressed as colony forming units (CFU)/ml.
CFU at the 0 h time point reflects the amount of phagocytosis by the cultured RAW 264.7 cells
and PECs, while the reduction in CFU at 4 and 24 h time points reflects the killing of
intracellular bacteria by the cells. As Echinacea treatment induced some changes in eukaryotic
cell growth (see Figure 1), the intracellular bacteria quantitation was adjusted based on the
parallel MTS assay to normalize each treatment group to the same cell count before bacterial
infection by using the formula: number of intracellular bacteria = number of viable bacteria
counted × (control cells MTS OD)/(treated cells MTS OD).
Nitrite assay
NO in the presence of oxygen is rapidly converted to nitrite. Supernates collected from RAW
264.7 cells and PECs cultured with and without LPS or with Salmonella (as described above)
were tested for nitrite based on the Griess reaction (Chou et al. 1997). The absorbance at 550
nm was measured using a microplate reader. The cell-free culture medium alone containing a
trace amount of nitrite was subtracted from each value obtained with cells. The NO levels were
calculated based upon the absorbance of sodium nitrite (0.39–100 μM) as a standard. The NO
levels in supernates from RAW 264.7 cells post Salmonella infection were adjusted based on
the MTS data to normalize for differences in cell number.
In the absence of LPS, very low amounts of NO (<0.5 μM) were measured in culture supernates
from RAW 264.7 cells incubated in vitro for 24 h. Thus, we report only NO production of
cultures from LPS stimulated cells.
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Cytokine assays
Supernates from RAW 264.7 cells and PECs incubated with LPS for 24 h (as described above)
were assayed for TNF-α (RAW 264.7 cells) or IL-1β and IL-10 (PECs) by enzyme-linked
immunosorbent assay (ELISA). In the absence of LPS in vitro, very low (or lower than limit
of detection) amounts of the cytokines of interest were measured in culture supernates of both
RAW 264.7 cells and PECs. In the presence of LPS, RAW 264.7 cells secrete high levels of
TNF-α and PECs secrete high levels of IL-1β and IL-10. ELISAs for these cytokines were
conducted according to the manufacturer’s protocols (BD Biosciences, San Diego, CA, USA).
The cytokine levels were calculated using purified recombinant mouse cytokines as a standard.
Statistical analysis
Statistix software (version 8.0, Analytical Software, Tallahasee, FL, USA) was used for the
statistical analysis. Differences between the vehicle and other groups were tested by two-way
analysis of variance (group × experiment). A p value <0.05 was considered significant.
Results
Phytochemical analysis
Echinacea alcohol extracts contain several chemical components. Lipophilic alkamides and
hydrophilic caffeic acid derivatives are two groups of the most studied metabolites. The
concentrations of phytochemicals identified and quantified using HPLC are listed in Table I.
Alkamides were the major phytochemicals detected, especially in EA and EP alcohol extracts.
Note that amides 7 and 8 appear in the present EPA extracts though they were undetectable in
our previously prepared alcohol extracts (Zhai et al. 2007). Among the caffeic acid derivatives,
echinacoside was found in higher quantities in both EA and EPA extracts, while cichoric acid
was the main form in EP extract.
In vitro experiments
Before measurement of the production of inflammatory mediators by RAW 264.7 cells, we
first evaluated the cytotoxicity of Echinacea alcohol extracts by using the MTS-based assay.
Echinacea alcohol extracts displayed different patterns of effects in the presence as opposed
to the absence of LPS (Figure 1). In the absence of LPS, all three alcohol extracts at 200 and
500 μg/ml significantly increased cell number when these two groups were jointly compared
to the vehicle control, but in the presence of LPS, EPA and EP at 500 μg/ml significantly
decreased cell number when compared to cells treated with vehicle (0.25% ethanol) (p values
≤0.006). Treating RAW 264.7 cells with the vehicle had modest effects on cell number. The
vehicle, in comparison to the baseline control, decreased cell number in the absence of LPS,
but increased cell number when LPS was present.
To assess the effect of Echinacea alcohol extracts on NO production, RAW 264.7 cells were
exposed to LPS plus alcohol extracts for 24 h. The alcohol extracts reduced NO production in
a dose-dependent manner (Figure 2A). In comparison to the vehicle control, EPA at 100 μg/
ml significantly decreased the production of NO (p = 0.009). When the herbal concentration
was raised to 200 μg/ml, NO production was significantly inhibited by all three alcohol extracts
(p values ≤0.042). None of the three alcohol extracts at the concentrations tested interfered
with the reaction between nitrite and the Griess reagent (data not shown).
RAW 264.7 cells activated by LPS secrete high levels of TNF-α (reaching up to 9000 pg/ml).
The effect of Echinacea alcohol extracts on the TNF-α levels was evaluated in the same culture
supernates analyzed for the NO levels. All three extracts had a similar inhibitory effect on TNF-
α secretion as on NO production (Figure 2B). When compared to the vehicle control, both EPA
and EP at a concentration of 100 μg/ml significantly decreased TNF-α secretion (p<0.02 and
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p<0.0001, respectively). EA, EPA and EP at the highest concentration tested of 200 μg/ml also
inhibited TNF-α secretion (p values <0.04).
After incubation with Echinacea alcohol extracts overnight, RAW 264.7 cells were assessed
for phagocytosis (CFU at 0 h) and bacterial killing (reduction in CFU at 4 and 24 h) after the
addition of Salmonella. Figure 3 shows the survival of bacteria in RAW 264.7 cells pretreated
with one of the three alcohol extracts in the absence of LPS. Incubation of RAW 264.7 cells
with EA at 100–200 μg/ml enhanced the subsequent phagocytosis (p values < 0.04), but
inhibited bacterial killing at 4 (p values < 0.026) and 24 h (p values < 0.026) post-infection.
EPA displayed no significant effects on bacterial phagocytosis, but increased bacterial killing
over 24 h incubation (p = 0.002 at 200 μg/ml). EP had no effect on bacterial phagocytosis, but
later decreased bacterial killing. EP at 100–200 μg/ml significantly inhibited bacterial killing
4 h post-infection (p values < 0.037). At 24 h post-infection, EP at 10 μg/ml also showed an
inhibitory effect on bacterial killing (p = 0.011).
NO production was also evaluated in the culture of RAW 264.7 cells following exposure to
Salmonella (Figure 4). RAW 264.7 cells pretreated with Echinacea alcohol extracts showed a
dose-related trend of decreased NO production 24 h after exposure to bacteria. When compared
to the vehicle, EA and EPA at 200 μg/ml significantly inhibited NO production when assayed
at 24 h post-infection (p = 0.036 and p = 0.018, respectively). At 4 h post-infection, EP at 100
μg/ml significantly decreased NO production (p = 0.030), but the decrease in NO was not
significant at the 24-h time point for EP.
Ex vivo experiments
Parallel studies were performed using proteose peptone-elicited PECs. After mice were
gavaged with Echinacea alcohol extracts for seven consecutive days, PECs were harvested and
incubated overnight in the absence or presence of LPS. There were no significant differences
in cell number as determined by the MTS assay (Figure 5A) and NO production (Figure 5B)
between the vehicle control and any of the Echinacea treatment groups. In addition, no
significant differences in the secretion of cytokines IL-1β and IL-10 in culture supernates of
PECs in the presence of LPS were associated with oral administration of the extracts compared
to the vehicle control (Figure 5C). For all these assays of PECs (cell viability, NO production
and cytokines), no significant difference was observed between the two control groups (the no
gavage control and the vehicle control).
After incubation of PECs overnight without LPS stimulation, cells were further assessed for
phagocytosis and bacterial killing as well as NO production at 0, 4 and 24 h post-infection. In
comparison to the no gavage control, the vehicle control displayed significantly decreased
phagocytosis (p < 0.02) (Figure 6A). However, one of the three extracts, EPA, showed a
marginal increase in bacterial phagocytosis over the vehicle control (p = 0.052). With
increasing time after infection, there were no significant differences in bacterial killing between
the vehicle control and any of other groups. Measurement of NO production post-infection
showed that mice gavaged with the vehicle displayed increased potential in NO production
and a significant increase in the vehicle control was found at 4 h after infection compared to
the no gavage mice (p < 0.05) (Figure 6B). Conversely, three Echinacea treatments showed,
to some extent, decreased NO production when compared to the vehicle control, and EP
exhibited a significant decrease in NO production compared to the vehicle control (p < 0.03)
at 4 h, but not 24 h post-infection.
Discussion
This study demonstrates that Echinacea alcohol extracts in vitro inhibit LPS-induced
generation of NO and TNF-α in macrophages. Although NO and TNF-α are needed for clearing
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and containing bacterial infection, excessive NO and TNF-α are implicated in a pathological
role in inflammatory responses. Such an inhibitory property may endow Echinacea alcohol
extracts as an effective anti-inflammatory remedy. In the present study, we found evidence that
Echinacea can decrease inflammatory mediators in vitro, but that the effect in vivo was
observed only in comparison with the vehicle control group, which exhibited an excessive
production of NO during Salmonella infection. Interestingly enough the excessive NO
production and suppressed NO production did not correlate with any biological effects of
bacterial killing in the PECs.
Echinacea alcohol extracts consist of both hydrophilic and lipophilic fractions. There is
evidence to believe that polar caffeic acid derivatives have anti-inflammatory activities
(Speroni et al. 2002). There are several types of caffeic acid derivatives in Echinacea (Table
I). Echinacoside was predominately present in EPA and EA, whereas cichoric acid was the
principal caffeic acid derivative of EP. In recent years, much attention has been paid to the
antioxidant activities and free radical scavenging abilities of Echinacea-derived caffeic acid
derivatives (Facino et al. 1995; Hu & Kitts 2000; Pellati et al. 2004; Dalby-Brown et al.
2005). The alkamide mixture of Echinacea alone shows weak or no antioxidant activity,
however, the alkamides have been found to significantly increase the antioxidant activity of
the caffeic acid derivatives, possibly due to the lipophilic nature of the alkamides (Dalby-
Brown et al. 2005). Moreover, individual alkamides and mixtures of alkamides have been
reported to have anti-inflammatory effect by inhibiting NO production in LPS-stimulated
macrophages in vitro (Chen et al. 2005). The observed inhibition of inflammatory mediators
by Echinacea alcohol extracts in vitro in the present study might be due to the additive or
synergistic action of hydrophilic fractions (caffeic acid derivatives) and lipophilic fractions
(alkamides).
The NO and TNF-α inhibitory potential of the three alcohol extracts in vitro is generally EPA
> EP > EA. The basis of this difference in the modulation of NO and TNF-α production may
rest on the distinct amounts and types of phytochemicals between the three herbal preparations.
HPLC data showed that EPA and EP had higher levels of echinacoside or cichoric acid,
respectively, and they share high levels of some individual alkamides, such as alkamide 2 that
occurs in relatively small amount in EA. These herbal components may be quantitatively
important as modulators of NO and TNF-α production. Further studies are needed to address
the respective role of individual phytochemicals and their interaction in the modulation of
inflammatory mediators.
NO generated by LPS-activated macrophages is a strong inducer of cell damage and apoptosis
(Brune et al. 1997; Chang et al. 2000). The downregulation of NO production by Echinacea
alcohol extracts possibly protects macrophages from NO damage. Since production of TNF-
α and NO by macrophages are precisely controlled by several ubiquitous transcription factors
including NF-κB (Baeuerle & Baltimore 1996), Echinacea-mediated reduction of both
inflammatory mediators probably results from the perturbance of a common upstream signaling
pathway.
Interestingly, Sharma et al. (2006) recently reported that an alcohol tincture from EP roots
increased the nuclear expression of multiple pro-inflammatory transcription factors (e.g. NF-
κB and STATs) in non-activated human bronchial epithelial cell line BEAS-2B, but inhibited
the expression of these transcription factors when the cells were infected with rhinovirus, thus
providing strong mechanistic evidence to explain the observed phenomena in this study; that
is, Echinacea alcohol extracts have different influences on the non-activated and activated
macrophages, and the effects of Echinacea on the inflammatory mediators are associated with
the modulation of transcription factor expression.
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The opposite effects of Echinacea alcohol extracts on the non-activated and activated
macrophages were also seen in cell numbers with the use of the MTS assay (Figure 1). In
comparison to the vehicle, Echinacea resulted in decreased cell number in the presence of LPS.
While macrophages are in a resting state, Echinacea stimulated, to some extent, an increase in
cell number. Echinacea alcohol extracts might stimulate the non-activated macrophages (e.g.
increase cell number and/or function), but reduce macrophage proliferation when they are
activated.
Macrophages constitute one of the first lines of host defense against microbial infections based
on their abilities to produce NO and reactive oxygen species. NO is believed to represent an
important effector molecule in the killing of a variety of pathogens including Salmonella
(MacMicking et al. 1997; Burgner et al. 1999; Alam et al. 2002; Babu et al. 2006). Since
Echinacea preparations, mainly from fresh-pressed juice or the high molecular weight
polysaccharide fraction, have been shown to upregulate production and secretion of
proinflammatory cytokines and oxygen radicals, consistent with an immune activated
antimicrobial effect (Stimpel et al. 1984; Steinmuller et al. 1993; Burger et al. 1997), it is
interesting to know the possible consequence upon inhibition of NO production by Echinacea
alcohol extracts. We attempted to investigate and correlate the phagocytic activity and bacterial
killing of macrophages with NO production following exposure to Echinacea alcohol extracts.
Although EA enhanced phagocytic activity, treatment with EA or EP clearly showed an
inhibitory effect on intracellular bacterial killing. This inhibition may be a secondary effect of
the downregulation of NO production. Macrophages infected with bacteria produce high levels
of NO that can be blocked by alcohol extracts of Echinacea, especially at high concentrations.
Nonetheless, EPA at 200 μg/ml simultaneously increased the potential of bacterial killing but
inhibited NO production by macrophages. A reasonable explanation is that macrophages may
depend on multiple mediators (i.e. reactive oxygen intermediates (Cherayil & Antos 2001)),
not just NO, to provide them with Salmonella-killing activity.
RAW 264.7 cells closely resemble the murine peritoneal macrophages in their response to
inflammatory stimuli and pathogenic microbes. We expected that Echinacea alcohol extracts
could exert a similar, although not identical, effect on PECs as they did on the macrophage-
like RAW 264.7 cells. Unfortunately, a weak in vivo effect on inflammatory PECs was seen.
The only notable change in PECs was an EP-mediated reduction in NO production at the 4-h
time point after Salmonella engulfment. Interestingly, the reduction in NO production did not
result in a significant decrease in bacterial killing. The in vivo effect in this regard might be
largely influenced by several factors, such as the metabolism of the phytochemicals, the
activation state of PECs and the complex in vivo environment (e.g. constitutive expression of
cytokines, growth factors and hormones (Pruett et al. 2005)). Although inflammatory agents,
such as proteose peptone and thioglycollate, are commonly applied to induce an inflammatory
response resulting in an influx of strongly activated macrophages into the peritoneum and thus
an increased peritoneal macrophage yield, it is unclear as to how and to what extent these
inflammatory agents affect the functional state of macrophages (Fortier & Falk 1994). On the
other hand, lack of an inhibitory effect of orally administered Echinacea alcohol extracts on
bacterial phagocytosis and killing by PECs may indicate that Echinacea will not adversely
affect these important innate immune functions.
To summarize, Echinacea alcohol extracts have a potential anti-inflammatory activity, but this
effect was mainly observed in vitro, especially at relatively high concentrations of the extracts.
Increased knowledge of the biological properties and the mode of action of the physiologically
relevant concentrations of Echinacea alcohol extracts are necessary.
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Figure 1.
Viability of RAW 264.7 cells exposed to Echinacea alcohol extracts. E. angustifolia, EA; E.
pallida, EPA; E. purpurea, EP. Cells were treated with the extracts in the presence (B) or
absence (A) of LPS (1 μg/ml). Cell viability was determined by the MTS assay. Data are
expressed as mean ± standard error of the mean of three independent experiments in duplicates.
Absorbance of baseline LPS treated cells (no vehicle and no alcohol extracts) was expressed
as 100%. *p < 0.05 for the individual group versus the corresponding vehicle control.
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Figure 2.
Effect of Echinacea alcohol extracts on NO production and TNF-α secretion in LPS-activated
RAW 264.7 cells. E. angustifolia, EA; E. pallida, EPA; E. purpurea, EP. Cells were incubated
in the presence of LPS (1 μg/ml) and alcohol extracts for 24 h. The culture supernates were
harvested for nitrite accumulation (A) and TNF-α (B) assays. Data are expressed as mean ±
standard error of the mean of three independent experiments in duplicates. Values of LPS
treated cells cultured with vehicle were referred to as 100%. *p < 0.05 for the individual group
versus the corresponding vehicle control.
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Figure 3.
Survival of Salmonella within RAW 264.7 cells pretreated with indicated concentrations of
Echinacea alcohol extracts. E. angustifolia, EA; E. pallida, EPA; E. purpurea, EP. Cells were
infected at an MOI of 100:1 for 2 h. At set time points, internalized bacteria were assessed by
gentamicin protection assay. Data are expressed as mean ± standard error of the mean of three
independent experiments in duplicates. *p < 0.05 for the individual group versus the vehicle
control at the same time point.
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Figure 4.
NO production by RAW 264.7 cells infected with Salmonella at an MOI of 100:1 for 2 h. E.
angustifolia, EA; E. pallida, EPA; E. purpurea, EP. Before infection, cells were treated with
indicated concentrations of Echinacea alcohol extracts overnight. At set time points after
exposure to bacteria, NO production was measured by the Griess reaction. Data are expressed
as mean ± standard error of the mean of three independent experiments in duplicates. *p < 0.05
for the individual group versus the vehicle control at the same time point.
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Figure 5.
Effect of Echinacea alcohol extracts in vivo on cell viability of PECs as well as NO and cytokine
release by PECs. E. angustifolia, EA; E. pallida, EPA; E. purpurea, EP. Upon completion of
Echinacea administration at 130 mg/kg per day for seven days, PECs were harvested and
incubated in the absence or presence of LPS (1 μg/m) for 24 h. The culture supernates were
harvested for nitrite accumulation and cytokine assays. Cells were assessed for viability by the
MTS assay. Only cytokine data with LPS stimulation are shown. Data are expressed as mean
± standard error of the mean of three independent experiments in duplicates.
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Figure 6.
Survival of Salmonella within PECs (A) and NO production by PECs (B) harvested from mice
treated with Echinacea alcohol extracts. E. angustifolia, EA; E. pallida, EPA; E. purpurea, EP.
PECs were infected at an MOI of 100:1 for 2 h. At set time points, internalized bacteria were
assessed by gentamicin protection assay and nitrite accumulation in the culture assayed by the
Griess reaction. Data are expressed as mean ± standard error of the mean of three independent
experiments in duplicates. *p < 0.05 and #p < 0.1 for the individual group versus the vehicle
control at the same time point.
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